Cytokinetics, Incorporated (CYTK) - Buy, Sell or Hold?
Sector: Consumer Durables Sub-Sector: Major Pharmaceuticals
| Trade Date | Current Candlestick Pattern | Previous Candlestick Pattern | When | Performance Since |
|---|---|---|---|---|
| Tue, 28 Nov 2017 | None | Bullish Engulfing | Fri, 03 Nov 2017 | -46.69% |
| ***Stock database and scans are updated around midnight (New York time) every trading day. | ||||
7.25 0.00 (0%) Nov 28 4:00pm EDT
Open: 7.80 Range: 7.15 - 7.84 Vol: 2.11M Avg Vol: 471.83K
Analyze "CYTK" - FREE 30 Day Trial of Market Analyst 7
Short Term: Trend is Down
Last Trade is below the 5 day moving average at 7.78
Medium Term: Trend is Down
Last Trade is below the 20 day moving average at 11.11
Last Trade is below the 50 day moving average at 13.27
Long Term: Trend is Down
Last Trade is below the 200 day moving average at 13.33
* Data normalized for Splits & Dividends. Report data issues
How to use this info: Stock Timing With Moving Averages
How to use this info: Stock Timing With Moving Averages
News on "CYTK" Stock
- Cytokinetics to Announce Third Quarter Results on November 1, 2018
- Cytokinetics Unveils Expanded Development Pipeline and Provides Key Updates on Late-Stage Clinical Research Programs at R&D Day
- Report: Developing Opportunities within Denny's, Cytokinetics, Beazer Homes, Heidrick & Struggles International, Equity Commonwealth, and Spok — Future Expectations, Projections Moving into 2018
- The Week Ahead In Biotech: Conferences, Clinical Trial Results And IPOs
- Cytokinetics and Astellas Provide Updates Regarding Collaborative Skeletal Muscle Program
| Consumer Durables Stocks Above 200 Day Moving-Average | |||
|---|---|---|---|
| Ticker | Name | Trend Analysis | Support/Resistance |
| DVAX | Dynavax Technologies Corporation | Buy, Sell or Hold | Trading Levels & Pivots |
| KAMN | Kaman Corporation | Buy, Sell or Hold | Trading Levels & Pivots |
| SNTA | Synta Pharmaceuticals Corp. | Buy, Sell or Hold | Trading Levels & Pivots |
| CENT | Central Garden & Pet Company | Buy, Sell or Hold | Trading Levels & Pivots |
| BSPM | Biostar Pharmaceuticals, Inc. | Buy, Sell or Hold | Trading Levels & Pivots |
| IMGN | ImmunoGen, Inc. | Buy, Sell or Hold | Trading Levels & Pivots |
| AVEO | AVEO Pharmaceuticals, Inc. | Buy, Sell or Hold | Trading Levels & Pivots |
| ARQL | ArQule, Inc. | Buy, Sell or Hold | Trading Levels & Pivots |
| LGND | Ligand Pharmaceuticals Incorporated | Buy, Sell or Hold | Trading Levels & Pivots |
| NATR | Nature's Sunshine Products, Inc. | Buy, Sell or Hold | Trading Levels & Pivots |
Stock Trend Analysis - Buy, Sell or Hold "Cytokinetics, Incorporated" (CYTK)?
Although CYTK is currently trading below its 200 day moving average, it is prudent to note that in the last 52 weeks, CYTK has been trading above the 200 day moving average for 88% of the time with an average daily volume of 471.8K shares changing hands. This could portend a sustained reversal in trend, or just a slight bump in the road prior to resuming its bullish bias.The 50 day moving average indicates a medium term trading range with a bullish upside inclination. The 20 day moving average is however on a slight bearish bias, otherwise, it is also indicating range bound trading. Objectively, as long as CYTK is trading below its 200 SMA, rallies will be sold into and traders can expect a lot of resistance near the 200 SMA currently at 13.33. Technically there are too many uncertainties to recommend a buy on this stock at this moment. Click here for the latest support & resistance levels to help you finetune your entry into or exit out of "CYTK".The analyst consensus estimates for the 1 year price target for this stock is $22.25* (*source: Yahoo Finance).